News
Brookline Capital Initiates Coverage On Immunic with Buy Rating, Announces Price Target of $10
5 Apr 24
News, Price Target, Initiation, Analyst Ratings
Immunic And 2 Other Stocks Under $2 Insiders Are Buying
29 Feb 24
Long Ideas, News, Penny Stocks, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
Immunic Q4 EPS $(0.48) Beats $(0.51) Estimate, Cash And Equivalents As Of December 31, 2023 Were $46.7M
22 Feb 24
Earnings, News
Earnings Scheduled For February 22, 2024
22 Feb 24
Earnings
Immunic's Earnings Outlook
21 Feb 24
Earnings
Press releases
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
4 Apr 24
Press Releases
Immunic to Host MS R&D Day and Participate in Investor Conferences in April
4 Apr 24
Press Releases
Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
21 Mar 24
Immunic secures key patent, boosting MS drug exclusivity and global IP strategy
21 Mar 24
Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
8 Mar 24
Immunic to Participate in Investor and Scientific Conferences in March
7 Mar 24
Press Releases
Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
29 Feb 24
Press Releases
Immunic reports successful 2023 and prepares for key 2025 milestones
22 Feb 24
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
22 Feb 24
Earnings, Press Releases
Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update
15 Feb 24
Press Releases
Immunic to Participate in Investor and Scientific Conferences in February
1 Feb 24
Press Releases